Trials / Not Yet Recruiting
Not Yet RecruitingNCT07254234
A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease
Exploratory Study to Assess Utility of RetiSpec Artificial Intelligence Powered Retinal Imaging Solution in Detecting Amyloid Pathology in United Arab Emirates Nationals With Mild Impairment of Cognition
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the use of a screening tool to detect changes in the eye that are associated with Alzheimer's disease in adult participants with memory issues. For each participant, the study will last up to one month and requires one visit to the research site.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Retinal scan | Detailed image of the retina. |
| OTHER | Blood test | Sample will be used to test for a specific form of a protein in the blood to learn more about early detection of Alzheimer's disease. |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2025-11-28
- Last updated
- 2025-11-28
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT07254234. Inclusion in this directory is not an endorsement.